Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to obtain further information on the tolerability and efficacy of Atrovent® inhalets in
the treatment of Chronic Obstructive Pulmonary Disease under conditions of daily practice